Health Condition 1: L649- Androgenic alopecia, unspecified
Conditions
Interventions
Intervention1: Injectable platelet rich fibrin (iPRF): Injectable platelet rich fibrin (iPRF) monthly sessions for 6 months plus topical 5 % minoxidil topically twice daily. the total duration of inte
Sponsors
Dr FARKHANDA SOFI
Eligibility
Inclusion criteria
Inclusion criteria: Androgenetic alopecia Norwood Hamilton grade III- V No history of treatment with PRP or Finasteride in the past 6 months. No history of minoxidil oral or topical for at least 2 months prior to study.
Exclusion criteria
Exclusion criteria: Active scalp infections or skin diseases (psoriasis, eczema). Patients on systemic immunosuppressive or steroid therapy. Known hypersensitivity to minoxidil or any other study components. Prior hair transplantation. Any coagulation disorder or thrombocytopenia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in hair density as indicated by hair count/cm2 by trichoscopy.Timepoint: At 0, 6 and 12 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| Difference between the response of injectable platelet rich fibrin (iPRF) and microneedling in different stages of androgenetic alopecia. maintainence period of response achieved for a further 6 month follow up period. dermatology life quality index assessment (DLQI) Timepoint: 0, 6. 12 months. | — |
Countries
India
Contacts
Public ContactFarkhanda Sofi
ALL INDIA INSTITUTE OF MEDICAL SCIENCES GORAKHPUR
Outcome results
None listed